Search results for "MINOS"

showing 10 items of 739 documents

Cycloartane Glycosides from Astragalus erinaceus

2012

WOS: 000306925400004

lcsh:Chemistrylcsh:QD241-441lcsh:QD1-999lcsh:Organic chemistryAstragalus erinaceuslcsh:BotanycycloartaneAstragaluserinaceusLeguminosaeAstragalus erinaceus; Cycloartane; Glucuronic acid; Leguminosae; Saponin;saponinglucuronic acidlcsh:QK1-989Records of Natural Products
researchProduct

The ALHAMBRA survey: B -band luminosity function of quiescent and star-forming galaxies at 0.2 ≤  z  < 1 by PDF analysis

2016

[Aims]: Our goal is to study the evolution of the B-band luminosity function (LF) since z ∼ 1 using ALHAMBRA data. [Methods]: We used the photometric redshift and the I-band selection magnitude probability distribution functions (PDFs) of those ALHAMBRA galaxies with I ≤ 24 mag to compute the posterior LF. We statistically studied quiescent and star-forming galaxies using the template information encoded in the PDFs. The LF covariance matrix in redshift - magnitude - galaxy type space was computed, including the cosmic variance. That was estimated from the intrinsic dispersion of the LF measurements in the 48 ALHAMBRA sub-fields. The uncertainty due to the photometric redshift prior is also…

luminosity function mass function [Galaxies]Galaxies: statisticsAstrophysics::High Energy Astrophysical PhenomenaPopulationAstrophysics::Cosmology and Extragalactic AstrophysicsAstrophysics01 natural sciencesLuminositystatistics [Galaxies]0103 physical scienceseducation010303 astronomy & astrophysicsAstrophysics::Galaxy AstrophysicsPhotometric redshiftLuminosity function (astronomy)Physicseducation.field_of_study010308 nuclear & particles physicsGalaxies: luminosity function mass functionGalaxies: evolutionAstronomy and AstrophysicsCosmic varianceB bandevolution [Galaxies]Astrophysics - Astrophysics of GalaxiesRedshiftGalaxy[PHYS.ASTR.GA]Physics [physics]/Astrophysics [astro-ph]/Galactic Astrophysics [astro-ph.GA]Space and Planetary ScienceHigh Energy Physics::ExperimentAstrophysics::Earth and Planetary Astrophysics[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]Astronomy & Astrophysics
researchProduct

Demo 82. Lanzador de combustión y transformaciones de energía

2013

Objetivo: Ilustrar la transformación de la energía de unas formas en otras. Reconocer la energía útil de aquella que se “pierde” para el proceso de interés. Razonar termodinámicamente sobre el proceso de combustión.

mecánicaenergía luminosacalortermodinámicaenergía eléctricaenergía químicapiezoelectricidadcombustiónenergía acústicatipos de energíaenergía potencialcinética
researchProduct

Discovery of slow X-ray pulsations in the high-mass X-ray binary 4U 2206+54

2008

Context. The source 4U 2206+54 is one of the most enigmatic high-mass X-ray binaries. In spite of intensive searches, X-ray pul- sations have not been detected in the time range 10−3–103 s. A cyclotron line at ∼30 keV has been suggested by various authors but never detected with significance. The stellar wind of the optical companion is abnormally slow. The orbital period, initially reported to be 9.6 days, disappeared and a new periodicity of 19.25 days emerged. Aims. The main objective of our RXTE monitoring of 4U 2206+54 is to study the X-ray orbital variability of the spectral and timing parameters. The new long and uninterrupted RXTE observations allow us to search for long (∼1 h) puls…

media_common.quotation_subjectAstrophysics::High Energy Astrophysical Phenomenapulsars : general [Stars]X-ray binaryFOS: Physical sciencesOrbital eccentricityAstrophysicsAstrophysicsStars : early-type; Stars : emission-line Be; Stars : binaries : close; X-rays : binaries; Stars : pulsars : generalLuminosityearly-type [Stars]:ASTRONOMÍA Y ASTROFÍSICA::Cosmología y cosmogonia::Fuentes de Rayos X [UNESCO]UNESCO::ASTRONOMÍA Y ASTROFÍSICA::Cosmología y cosmogonia::Fuentes de Rayos XAstrophysics::Solar and Stellar AstrophysicsEccentricity (behavior)binaries : close [Stars]media_commonLine (formation)PhysicsAstrophysics (astro-ph)Astronomy and AstrophysicsOrbital periodLight curveNeutron starSpace and Planetary Scienceemission-line Be [Stars]binaries [X-rays]Astrophysics::Earth and Planetary AstrophysicsUNESCO::ASTRONOMÍA Y ASTROFÍSICA::Cosmología y cosmogonia::Estrellas:ASTRONOMÍA Y ASTROFÍSICA::Cosmología y cosmogonia::Estrellas [UNESCO]
researchProduct

8.4GHz VLBI observations of SN2004et in NGC6946

2007

We report on 8.4GHz Very Long Baseline Interferometry (VLBI) observations of the type II-P supernova SN2004et in the spiral galaxy NGC 6946, made on 20 February 2005 (151 days after explosion). The Very Large Array (VLA) flux density was 1.23$\pm$0.07 mJy, corresponding to an isotropic luminosity at 8.4GHz of (4.45$\pm$0.3)$\times10^{25}$ erg s$^{-1}$ Hz$^{-1}$ and a brightness temperature of (1.3$\pm$0.3)$\times10^{8}$ K. We also provide an improved source position, accurate to about 0.5 mas in each coordinate. The VLBI image shows a clear asymmetry. From model fitting of the size of the radio emission, we estimate a minimum expansion velocity of 15,700$\pm$2,000 km s$^{-1}$. This velocity…

media_common.quotation_subjectFOS: Physical sciencesIndividualAstrophysicsUNESCO::ASTRONOMÍA Y ASTROFÍSICAAstrophysicsAsymmetryLuminositylaw.inventionlawVery-long-baseline interferometryNGC 6946media_commonPhysicsSpiral galaxyImage (category theory)Astrophysics (astro-ph)Astronomy and AstrophysicsGalaxiesStars:ASTRONOMÍA Y ASTROFÍSICA::Cosmología y cosmogonia [UNESCO]SynchrotronSupernovaRadio continuumSupernovaeSpace and Planetary ScienceBrightness temperatureGalaxies ; Individual ; NGC 6946 ; Radio continuum ; Stars ; Supernovae ; SN 2004etUNESCO::ASTRONOMÍA Y ASTROFÍSICA::Cosmología y cosmogoniaSN 2004et:ASTRONOMÍA Y ASTROFÍSICA [UNESCO]
researchProduct

Different species and symbiotic genotypes of field rhizobia can nodulate Phaseolus vulgaris in Tunisian soils.

2002

Abstract A collection of 160 isolates of rhizobia nodulating Phaseolus vulgaris in three geographical regions in Tunisia was characterized by restriction fragment length polymorphism analysis of polymerase chain reaction (PCR)-amplified 16S rDNA, nifH and nodC genes. Nine groups of rhizobia were delineated: Rhizobium gallicum biovar (bv.) gallicum, Rhizobium leguminosarum bv. phaseoli and bv. viciae, Rhizobium etli bv. phaseoli, Rhizobium giardinii bv. giardinii, and four groups related to species of the genus Sinorhizobium, Sinorhizobium meliloti, Sinorhizobium medicae and Sinorhizobium fredii. The most abundant rhizobial species were R. gallicum, R. etli, and R. leguminosarum encompassing…

medicine.disease_causeSinorhizobium frediiApplied Microbiology and BiotechnologyMicrobiologyRhizobium leguminosarumRhizobiaMicrobiologyRhizobium gallicum03 medical and health sciencesRhizobium etliBotanymedicine[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesSinorhizobium melilotiEcologybiology030306 microbiologyfood and beveragesbiochemical phenomena metabolism and nutritionbiology.organism_classificationHARICOT[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologySinorhizobiumbacteriaRhizobiumFEMS microbiology ecology
researchProduct

Ascorbic Acid in Postoperative Intensive Care Patients - Biochemical Aspects and Clinical Experience

2009

The transport mechanisms of ascorbic acid (AA) are described. The metabolism of AA and its function as an antioxidant are covered in some detail. Subsequently, indications for postoperative substitution are discussed. The supplementation of up to 300 mg of AA per day in postoperative intensive care unit patients during par-/enteral nutrition is recommended to prevent hypovitaminosis. It is not clear if this is the optimal dosage of AA in postoperative/-trauma patients. New aspects for an AA substitution are discussed.

medicine.medical_specialtyAntioxidantmedicine.medical_treatmentAscorbic AcidBiochemistryGastroenterologyAntioxidantslaw.inventionHypovitaminosislawInternal medicineIntensive careDrug DiscoveryHumansMedicinePostoperative CarePharmacologybusiness.industryOrganic ChemistryAscorbic acidIntensive care unitSurgeryParenteral nutritionWounds and InjuriesMolecular MedicinebusinessCurrent Medicinal Chemistry
researchProduct

Fulminant bilateral Haemophilus influenzae keratitis in a patient with hypovitaminosis A treated with contaminated autologous serum

2011

We report on a patient with hypovitaminosis A treated with autologous serum (AS) who had bilateral infectious ulcers positive for Haemophilus influenzae. The patient suffered a perforation of his right eye and total healing of his left eye with a residual leukoma. In cases of severe malnutrition, serum levels of vitamins and bacteriostatic and growth factors are reduced, so AS would not only be ineffective but also increase the risk of secondary corneal infection. The prophylactic use of a topical antibiotic would be useful in treatment with AS, especially in patients who do not use and adequately store the eye drops, as in our patient.

medicine.medical_specialtyLeukomaCorneal Infectionbiologygenetic structuresbusiness.industryFulminantPerforation (oil well)Hypovitaminosis ACase Reportmedicine.diseasemedicine.disease_causeAutologous serumbiology.organism_classificationHaemophilus influenzaeeye diseasesSurgeryHaemophilus influenzaeKeratitisOphthalmologymedicinehypovitaminosis Abilateral infectious ulcerssense organsbusinessClinical Ophthalmology (Auckland, N.Z.)
researchProduct

Comparing medical treatments for Crohn’s disease

2013

The drugs available for inflammatory bowel disease are aminosalicylates, antibiotics, steroids, immunosuppressors and biologics. The effectiveness of these drugs has been evaluated in many randomized clinical trials, mainly versus placebo. Few studies have been conducted comparing the different drugs among themselves, owing to the methodological problems raised by comparative trials, such as sample size and blindness. This review focuses mainly on the randomized clinical trials that have compared different treatments. Of course comparisons are mainly between drugs used in a particular setting (mild, moderate and severe disease). However, on many occasions there is no homogeneity in these cl…

medicine.medical_specialtyPathologymedicine.drug_classAntibioticsAlternative medicineSevere diseasePlaceboInflammatory bowel diseaselaw.inventionBiological FactorsCrohn DiseaseRandomized controlled trialAdrenal Cortex HormoneslawInternal medicineAzathioprineIntestinal FistulaSecondary PreventionmedicineHumansBudesonideRandomized Controlled Trials as TopicCrohn's diseasebusiness.industryProbioticsHealth Policymedicine.diseaseAnti-Bacterial AgentsAminosalicylic AcidsMethotrexateSample size determinationbusinessJournal of Comparative Effectiveness Research
researchProduct

Secretory effect of azodisalicylate (azodisal sodium) on the short circuited mucosa of the rat ileum in vitro.

1988

Azodisalicylate (ADS) is one of the newly developed substitutes of sulphasalazine consisting of two molecules of 5-amino-salicylic acid. Azodisalicylate caused diarrhoea in some patients, apparently caused by an antiabsorptive secretagogue action of this compound. The mechanism of this was studied in the short circuited isolated mucosa of the rat ileum. Mucosal addition of ADS increased the potential difference (PD) and short circuit current (Isc) at a concentration of 1.3.10(-4) mol/l (4 mg/dl) with maximal effects at 1.3.10(-3) mol/l (40 mg/dl). Epithelial resistance was only slightly decreased at the higher concentrations of 40 and 100 mg/dl. Serosal ADS had no effect on electrical param…

medicine.medical_specialtySodiumIndomethacinchemistry.chemical_elementIleumIn Vitro TechniquesBiologyEpitheliumMembrane PotentialsChloridesIntestinal mucosaFurosemideIleumInternal medicinemedicineAnimalsSecretionIntestinal MucosaTranscellularMembrane potentialSodiumElectric ConductivityGastroenterologyStimulation ChemicalRatsAminosalicylic AcidsEndocrinologymedicine.anatomical_structureMechanism of actionchemistrySecretagoguemedicine.symptomResearch ArticleGut
researchProduct